Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2909-2912

  Goodarzi, Mark O ^a,b   Xu, Ning ^a   Azziz, Ricardo ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A7; PRASTERONE SULFATE; TESTOSTERONE; CYP3A7 PROTEIN, HUMAN; UNSPECIFIC MONOOXYGENASE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; UNITED STATES; BLOOD; GENETICS; METABOLISM;

ARYL HYDROCARBON HYDROXYLASES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; GENOTYPE; HUMANS; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE;

EID: 47549101437     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0403     Document Type: Article

References (18)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
2. Kumar A, Woods KS, Bartolucci AA, Azziz R 2005 Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 62:644-649
3. Yildiz BO, Goodarzi MO, Guo X, Rotter JI, Azziz R 2006 Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters. Fertil Steril 86:1688-1693
4. Stevens JC 2006 New perspectives on the impact of cytochrome P450 3A expression for pediatric pharmacology. Drug Discov Today 11:440-445
5. Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E 2001 Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27:383-391
6. Komori M, Nishio K, Kitada M, Shiramatsu K, Muroya K, Soma M, Nagashima K, Kamataki T 1990 Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry 29:4430-4433
7. Schuetz JD, Beach DL, Guzelian PS 1994 Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11-20
8. Miller KK, Cai J, Ripp SL, Pierce WM, Rushmore TH, Prough RA 2004 Stereo-and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450. Drug Metab Dispos 32:305-313
9. Smit P, van Schaik RH, van der Werf M, van den Beld AW, Koper JW, Lindemans J, Pols HA, Brinkmann AO, de Jong FH, Lamberts SW 2005 A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 90:5313-5316
10. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Cambridge, UK: Blackwell Scientific Publications; 377-384
11. Goodarzi MO, Guo X, Yildiz BO, Stanczyk FZ, Azziz R 2007 Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters. Am J Obstet Gynecol 196:398 e391-e395; discussion 398 e395-e396
12. Goodarzi MO, Antoine HJ, Azziz R 2007 Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome. J Clin Endocrinol Metab 92:2659-2664
13. Sim SC, Edwards RJ, Boobis AR, Ingelman-Sundberg M 2005 CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele. Pharmacogenet Genomics 15:625-631
14. Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, Zaya MJ 2003 Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307:573-582
15. Hammer F, Subtil S, Lux P, Maser-Gluth C, Stewart PM, Allolio B, Arlt W 2005 No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. J Clin Endocrinol Metab 90:3600-3605
16. Maruyama M, Matsunaga T, Harada E, Ohmori S 2007 Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells. Biol Pharm Bull 30:2091-2097
17. Greuet J, Pichard L, Bonfils C, Domergue J, Maurel P 1996 The fetal-specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture. Biochem Biophys Res Commun 225:689-694
18. Gambineri A, Vicennati V, Genghini S, Tomassoni F, Pagotto U, Pasquali R, Walker BR 2006 Genetic variation in 11β-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:2295-2302